Investors

GSK delivers first quarter 2026 results

Who we are

As a focused biopharma company, we discover, develop and deliver medicines and vaccines to create value for patients and shareholders. We aim to positively impact the health of 2.5 billion people by the end of the decade.

Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.

Purpose, strategy and culture

Why invest in GSK?

Respiratory, immunology and inflammation

deaths each year due to lung diseases

Go to respiratory, immunology and inflammation

Oncology

~10m

people die from cancer each year

Go to oncology

HIV

40m

people living with HIV globally

Go to HIV

Infectious diseases

1 in 7

deaths globally caused by infectious disease

Go to infectious diseases

Behind the Science

Exploring how today's discoveries are shaping tomorrow's health

Antibody-drug conjugates: Advancing the search for more targeted cancer treatment

Mapping disease at the cellular level: A single-cell revolution in drug discovery

Why adults aged 50 years and older with certain long-term health conditions need to make their move to help protect against this common respiratory virus

'The ever-present threat of contracting a UTI means my daily routine is ruled by measures to reduce my risk'

'We’re innovating to help keep COPD patients out of hospital and exacerbation-free'

'Prevention is the best medicine to stop disease before it starts'

‘I was the sickest anyone could ever be’: Why young people are at risk of meningitis and what needs to change to reduce it

‘Digital biological twins and organoids might sound like sci-fi, but they’re real – and we’re using them to fight cancer’

‘I feel hopeless and frustrated’: Why patients living with incurable blood cancers need more treatment options

‘Finding the right treatment for my asthma and nasal polyps has transformed my life. I hope my experience can help others achieve the same’

Read our magazine

INVESTORS

We announced our first quarter 2026 results on Wednesday 29 April

View latest results